EP1750739A4 - Oxygenated dibenzo-alpha-pyrone chromoproteins - Google Patents

Oxygenated dibenzo-alpha-pyrone chromoproteins

Info

Publication number
EP1750739A4
EP1750739A4 EP05779897A EP05779897A EP1750739A4 EP 1750739 A4 EP1750739 A4 EP 1750739A4 EP 05779897 A EP05779897 A EP 05779897A EP 05779897 A EP05779897 A EP 05779897A EP 1750739 A4 EP1750739 A4 EP 1750739A4
Authority
EP
European Patent Office
Prior art keywords
alpha
oxygenated dibenzo
pyrone chromoproteins
chromoproteins
pyrone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05779897A
Other languages
German (de)
French (fr)
Other versions
EP1750739A1 (en
Inventor
Shibnath Ghosal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natreon Inc
Original Assignee
Natreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/824,271 external-priority patent/US20050233942A1/en
Priority claimed from US10/799,104 external-priority patent/US20050245434A1/en
Application filed by Natreon Inc filed Critical Natreon Inc
Publication of EP1750739A1 publication Critical patent/EP1750739A1/en
Publication of EP1750739A4 publication Critical patent/EP1750739A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP05779897A 2004-04-14 2005-03-14 Oxygenated dibenzo-alpha-pyrone chromoproteins Withdrawn EP1750739A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/824,271 US20050233942A1 (en) 2004-04-14 2004-04-14 Oxygenated dibenzo-alpha-pyrone chromoproteins
US10/799,104 US20050245434A1 (en) 2004-04-30 2004-04-30 Oxygenated dibenzo-alpha-pyrone chromoproteins
PCT/US2005/008577 WO2005099739A1 (en) 2004-04-14 2005-03-14 Oxygenated dibenzo-alpha-pyrone chromoproteins

Publications (2)

Publication Number Publication Date
EP1750739A1 EP1750739A1 (en) 2007-02-14
EP1750739A4 true EP1750739A4 (en) 2010-05-05

Family

ID=35149775

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05779897A Withdrawn EP1750739A4 (en) 2004-04-14 2005-03-14 Oxygenated dibenzo-alpha-pyrone chromoproteins

Country Status (4)

Country Link
EP (1) EP1750739A4 (en)
JP (1) JP2008504231A (en)
CA (1) CA2562829A1 (en)
WO (1) WO2005099739A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050282781A1 (en) * 2004-06-18 2005-12-22 Shibnath Ghosal Compositions of stable bioactive metabolites of docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids
CZ2010591A3 (en) * 2010-08-02 2012-05-23 T-String Pardubice, A. S. Process for preparing mummy liposome
JP2017014154A (en) * 2015-07-01 2017-01-19 公立大学法人岡山県立大学 Hyaluronic acid production promoter containing urolithins
JP6799767B2 (en) * 2015-07-07 2020-12-16 公立大学法人岡山県立大学 Melanin production inhibitor containing urolithins
CN106666538A (en) * 2017-01-05 2017-05-17 徐文轩 Preparation method of dried day lilies
JP7152344B2 (en) * 2019-03-27 2022-10-12 富士フイルム株式会社 Oil-in-water cosmetics

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006078424A2 (en) * 2005-01-19 2006-07-27 Natreon, Inc. Polyherbal compositions and methods for treating viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405613A (en) * 1991-12-11 1995-04-11 Creative Nutrition Canada Corp. Vitamin/mineral composition
US6440436B1 (en) * 2001-05-18 2002-08-27 Natreon Inc. Process for preparing purified shilajit composition from native shilajit

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006078424A2 (en) * 2005-01-19 2006-07-27 Natreon, Inc. Polyherbal compositions and methods for treating viral infections

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GHOSAL S ET AL.: "The core structure of Shilajit Humus", SOIL BIOLOGY AND BIOCHEMISTRY, vol. 23, no. 7, 1991, GB, pages 673 - 680, XP023673371, ISSN: 0038-0717, DOI: 10.1016/0038-0717(91)90082-U *
GHOSAL S.: "Shilajit : its origin and significance", INDIAN JOURNAL OF INDIGENOUS MEDICINES, SUSHIEL KUMAR AGRAWAL, SAHARANPUR, IN, vol. 9, no. 1&2, 1992, pages 1 - 3, XP009131178, ISSN: 0971-5452 *
GHOSAL SHIBNATH: "Shilajit: Its origin and vital significance", TRADITIONAL MEDICINE INTERNATIONAL SCIENCE PUBLISHER {A}, LEBANON, NEW HAMPSHIRE, USA, 1993, & INTERNATIONAL SEMINAR ON TRADITIONAL MEDICINE: A CHALLENGE OF THE TWENTY-FIRST CENTURY; CALCUTTA, INDIA; NOVEMBER 7-9, 1992, pages 308 - 319, XP009033755, ISBN: 1-881570-32-0 *
See also references of WO2005099739A1 *

Also Published As

Publication number Publication date
WO2005099739A1 (en) 2005-10-27
JP2008504231A (en) 2008-02-14
EP1750739A1 (en) 2007-02-14
CA2562829A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
EP1717239A4 (en) Substituted sym-triindole
DE602005007474D1 (en) Substituierte morpholin- und thiomorpholinderivate
DE502005007040D1 (en) Laryngoskop
PL1711057T3 (en) Biocides
DE602004014986D1 (en) Terminal-box
DE502005007456D1 (en) Nanoemulsionen
DE602005008719D1 (en) Notinformationsschild
EP1732560A4 (en) Substituted cinnolin-4-ylamines
DE502005009795D1 (en) Modulares gelenkprothesensystem
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
ZA200702309B (en) C CRP precptor antagonisists
EP1750739A4 (en) Oxygenated dibenzo-alpha-pyrone chromoproteins
DE602005003029D1 (en) Polyaminoamidmonoepoxyaddukte
DE502004004685D1 (en) Giessmaschine
DE502005010653D1 (en) Eiten
GB0425137D0 (en) Blade
DE502005006813D1 (en) Common-rail-injektor
DE502004004917D1 (en) Multiaxialkomplex
GB0418238D0 (en) Up yours- Barb-B-Q
ZA200700723B (en) Substituted N-acyl-2-aminothiazoles
DE502005004945D1 (en) Auto-splice-system
TWM291371U (en) Compass
AU2909P (en) DT23 Dianella tasmanica
GB0422032D0 (en) Pottys up

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061110

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

A4 Supplementary search report drawn up and despatched

Effective date: 20100406

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/00 20060101ALI20100329BHEP

Ipc: A61K 38/00 20060101AFI20051104BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100706